Subdermal Contraceptive Implants Market: Etonogestrel Implant to Witness Significant Demand

Subdermal contraceptive implant is a tiny, thin rod about the size of a matchstick. The implant releases hormones slow and stable into the body to prevent pregnancy.

Subdermal Contraceptive Implants Market: Introduction

  • Subdermal contraceptive implant is a tiny, thin rod about the size of a matchstick. The implant releases hormones slow and stable into the body to prevent pregnancy. Subdermal contraceptive implant helps to prevent pregnancy for one to five years. The protection period depends upon specific progestin and the type of polymer.
  • Advantages of subdermal contraceptive implant include long-term contraceptive action without requiring the provider’s or user’s attention, low dose of highly effective contraception without the use of estrogen, and fertility is readily reversible after the removal of implant.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75805

Key Drivers and Restraints of Global Subdermal Contraceptive Implants Market

  • Rise in awareness about various birth control methods, introduction of several modern contraceptives in the market, and high per capita income are the major factors driving the global subdermal contraceptive implants market. According to the Guttmacher Institute, in 2018, nearly 21 million women needed publicly funded contraceptive services in the U.S. According to the Centers for Disease Control and Prevention, in 2017, around 214 million women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method.
  • Recently, the UN collaborated with NGOs to provide contraceptive implants in underdeveloped countries at low price. This acts as a major driver of the market. Additionally, increase in the use of long-term contraception methods in developing countries and surge in awareness about contraception are likely to propel the global market.

Request for Analysis of COVID-19 Impact on Subdermal Contraceptive Implants Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75805

Etonogestrel Implant to Witness Significant Demand

  • Based on type, the global subdermal contraceptive implants market can be segmented into etonogestrel implant, levonorgestrel implant, and others
  • The etonogestrel implant segment accounted for the largest share of the global subdermal contraceptive implants market in 2018. The segment is projected to dominate the global subdermal contraceptive implants market during the forecast period, as the implant is safe during breast feeding and improves symptoms of dysmenorrhea and endometriosis.

Pre book Subdermal Contraceptive Implants Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=75805&ltype=S

Hospitals Segment to Witness Significant Growth

  • In terms of end-user, the global subdermal contraceptive implants market can be divided into hospitals, clinics, and others
  • The hospitals segment accounted for the largest market share in terms of revenue in 2018 and is anticipated to grow at a rapid pace during the forecast period. This can be attributed to increase in number of subdermal contraceptive implant procedures performed in hospitals.

North America to Dominate Global Subdermal Contraceptive Implants Market

  • In terms of region, the global subdermal contraceptive implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global subdermal contraceptive implants market in 2018 and the trend is expected to continue during the forecast period. The region’s dominance can be attributed to increase in number of abortions, high number of unwanted pregnancies, presence of key market players in the region, greater affordability, and rise in demand for technologically advanced products. According to the Guttmacher Institute, in 2017, 862,000 abortions were carried out in U.S.
  • The market in Asia Pacific is likely to experience strong growth during the forecast period, owing to increase in adoption of new products, rise in awareness about contraceptives and STIs, and surge in disposable income in emerging countries such as India, China, and others.

Top of Form

Read More Information:

https://www.transparencymarketresearch.com/subdermal-contraceptive-implants-market.html

Key Manufacturers Operating in Global Market

The global subdermal contraceptive implants market was highly fragmented in 2018. Key manufacturers operating in the global market are:

  • Bayer AG
  • Merck & Co. Inc.
  • Shanghai Dahua Pharmaceutical Co., Ltd.

Browse More Market Reports:

Smart Implantable Pumps Market:

An implantable pump is a technologically advanced drug delivery system or device implanted beneath the skin to administer a steady dose of drug or fluid. These pumps are used to deliver anti-spasmodic, chemotherapeutic agents, and opioid drugs. The global smart implantable pumps market was valued at US$ 1,332.42 Mn in 2018 and is projected to expand at a CAGR of 8.0% from 2019 to 2027.

Thyroid Function Test Market:

The global thyroid function test market was valued at approximately US$ 1.3 Bn in 2018. It is anticipated to exceed a value of US$ 2.4 Bn by 2027, expanding at a CAGR of more than 5% from 2019 to 2027. The global thyroid function test market is driven by an increase in the incidence of thyroid disease, rise in geriatric population, increase in obese, diabetic, and cardiovascular patients, and increase in disease awareness programs in developing regions. Furthermore, high healthcare investment and increase in awareness related to thyroid function test are expected to create new opportunities in developing countries. However, asymptomatic nature of thyroid disorders leads to large undiagnosed population, which in turn is expected to restraint the market during the forecast period.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/